linagliptin vs metformin
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of linagliptin and metformin. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
moderate Known Drug Interaction
Drugs that Reduce Metformin Clearance Clinical Impact Concomitant use of drugs that interfere with common renal tubular transport systems involved in the renal elimination of metformin (e.g., organic cationic transporter-2 [OCT2] / multidrug and toxin extrusion [MATE] inhibitors such as ranolazine, vandetanib, dolutegravir, and cimetidine) could increase systemic exposure to metformin and may increase the risk for lactic acidosis [see Clinical Pharmacology (12.3) ] . Alcohol Clinical Impact Alcohol is known to potentiate the effect of metformin on lactate metabolism. ( 7 ) Drugs that...
Tradjenta
Glucophage, Fortamet, Glumetza
No summary available.
No summary available.
Information not available.
Information not available.
Information not available.
Information not available.
- • Runny nose or sore throat
- • Diarrhea
- • Diarrhea
- • Upper respiratory tract infection (like a cold)
- • Headache
- Blood Glucose Increased 1,326
- Diarrhoea 1,196
- Nausea 1,138
- Fatigue 1,028
- Dyspnoea 998
- Nausea 21,946
- Diarrhoea 21,884
- Blood Glucose Increased 18,328
- Fatigue 17,252
- Acute Kidney Injury 16,440
No specific warnings noted.
No specific warnings noted.
No pregnancy information available.
No pregnancy information available.
Also Compare, Nearby Drugs
Compare linagliptin with
How to Read This linagliptin vs metformin Comparison
linagliptin is classified in the DPP-4 Inhibitor drug class, while metformin sits within the Biguanide class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, linagliptin has 5,686 submissions while metformin has 95,850. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known moderate interaction flagged in FDA labeling, attributed to one drug may slow down how fast the other is removed from your body through your kidneys. this can cause a dangerous buildup of medicine and lead to a serious condition called lactic acidosis.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for linagliptin or metformin.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.